Clinical Trial Update: ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial comparing intermittent versus continuous PEG-asparaginase in childhood acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Pegaspargase (pegaspargase)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED